𝔖 Bobbio Scriptorium
✦   LIBER   ✦

3–38 Quality of Life of Postmenopausal Women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial

✍ Scribed by Vassilopoulou-Sellin, R.


Book ID
122710752
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
155 KB
Volume
16
Category
Article
ISSN
1043-321X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Anastrozole alone or in combination with
✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d